- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr David Blumenthal on AJMC's Contribution to Managed Care
Over the past 20 years, The American Journal of Managed Care has been a great addition to the literature on advanced care models and innovation in healthcare systems, said David Blumenthal, MD, president of The Commonwealth Fund.
Over the past 20 years, The American Journal of Managed Care has been a great addition to the literature on advanced care models and innovation in healthcare systems, said David Blumenthal, MD, president of The Commonwealth Fund.
"It's the place where things you don't see in the more traditional literature find a place, particularly things that are useful to managers in their daily work," he said.
Dr Blumenthal will be writing the special guest commentary in the April issue of The American Journal of Managed Care, which will be featured on the 20th anniversary page alongside all special guest commentaries from 2015.
Impact of Amivantamab-Lazertinib on EGFR, MET Resistance Alterations in NSCLC: Danny Nguyen, MD
September 15th 2025The combination of amivantamab and lazertinib in first-line non–small cell lung cancer (NSCLC) significantly reduces resistance mechanisms with implications for second-line treatment, said Danny Nguyen, MD, of City of Hope.
Read More
Disparities in Biomarker Testing Impact Nonsquamous NSCLC Outcomes: Surbhi Singhal, MD
September 6th 2025Surbhi Singhal, MD, of the University of California Davis, discussed disparities in biomarker testing among patients diagnosed with stage IV nonsquamous non–small cell lung cancer (NSCLC).
Read More
